ProfileGDS4459 / ENSG00000124614
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 93% 84% 97% 92% 93% 86% 96% 94% 96% 95% 90% 95% 97% 92% 97% 89% 83% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 17.6993
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.3484
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 38.9197
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 47.3792
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 57.8193
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.786
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 78.5696
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 88.194
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 98.5596
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 108.2295
GSM623474group B, liver allograft wedge biopsie placebo treatment 17.3490
GSM623475group B, liver allograft wedge biopsie placebo treatment 28.3495
GSM623476group B, liver allograft wedge biopsie placebo treatment 38.6597
GSM623477group B, liver allograft wedge biopsie placebo treatment 47.5592
GSM623478group B, liver allograft wedge biopsie placebo treatment 58.897
GSM623479group B, liver allograft wedge biopsie placebo treatment 67.0189
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.2683